Changes in autonomic nervous system activity after treatment with alpha-blocker in men with lower urinary tract symptoms

Purpose: To determine changes in autonomic nervous system activity after treatment in men with lower urinary tract symptoms (LUTS), we evaluated changes in patients' symptoms, uroflowmetry, and heart rate variability (HRV) after treatment with alpha-blockers for 12 weeks. Materials and Methods:...

Full description

Bibliographic Details
Main Authors: Kang Hee Shim, Tae Woo Kim, Byung Ha Chung, Sung Won Lee, Jong Kwan Park, Kwangsung Park, Jun Cheon, Kyung Seop Lee, Hyung-Jee Kim, Do-Hwan Seong, Seung-June Oh, Sae Woong Kim, Ji Youl Lee, Seol Ho Choo, Jong Bo Choi
Format: Article
Language:English
Published: Korean Urological Association 2018-01-01
Series:Investigative and Clinical Urology
Subjects:
Online Access:https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-59-49.pdf
id doaj-321f478d345d47bf81e59a7f90ae434d
record_format Article
spelling doaj-321f478d345d47bf81e59a7f90ae434d2020-11-24T23:36:24ZengKorean Urological AssociationInvestigative and Clinical Urology2466-04932466-054X2018-01-01591495410.4111/icu.2018.59.1.49Changes in autonomic nervous system activity after treatment with alpha-blocker in men with lower urinary tract symptomsKang Hee Shim0Tae Woo Kim1Byung Ha Chung2Sung Won Lee3Jong Kwan Park4Kwangsung Park5Jun Cheon6Kyung Seop Lee7Hyung-Jee Kim8Do-Hwan Seong9Seung-June Oh10Sae Woong Kim11Ji Youl Lee12Seol Ho Choo13Jong Bo Choi14Department of Urology, Ajou University College of Medicine, Suwon, KoreaDepartment of Urology, Ajou University College of Medicine, Suwon, KoreaDepartment of Urology and Urological Science Institute, Yonsei University College of Medicine, Seoul, KoreaDepartment of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, KoreaDepartment of Urology, Chonbuk National University School of Medicine, Jeonju, KoreaDepartment of Urology, Chonnam National University Medical School, Gwangju, KoreaDepartment of Urology, Korea University Anam Hospital, Seoul, KoreaDepartment of Urology, Dongguk University College of Medicine, Gyeongju, KoreaDepartment of Urology, Dankook University College of Medicine, Cheonan, KoreaDepartment of Urology, Inha University College of Medicine, Incheon, KoreaDepartment of Urology, Seoul National University Hospital, Seoul, KoreaDepartment of Urology, The Catholic University of Korea College of Medicine, Seoul, KoreaDepartment of Urology, The Catholic University of Korea College of Medicine, Seoul, KoreaDepartment of Urology, Ajou University College of Medicine, Suwon, KoreaDepartment of Urology, Ajou University College of Medicine, Suwon, KoreaPurpose: To determine changes in autonomic nervous system activity after treatment in men with lower urinary tract symptoms (LUTS), we evaluated changes in patients' symptoms, uroflowmetry, and heart rate variability (HRV) after treatment with alpha-blockers for 12 weeks. Materials and Methods: Ninety-five men who had LUTS (International Prostate Symptom Score [IPSS] ≥8) were included in this study. We divided them into two groups on the basis of a low frequency/high frequency (LF/HF) ratio of 1.6. After treatment with Xatral XL (Handok Inc., Korea) 10 mg for 3 months, we rechecked their IPSS, uroflowmetry, HRV and compared these with the baseline measurements. Results: Fifty-four men were assigned to the low LF/HF group (group A: LF/HF ≤1.6) and 41 men to the high LF/HF group (group B: LF/HF >1.6). At baseline and 12 weeks, none of the parameters differed significantly between the groups except for HF, which is one of the parameters of HRV. IPSS, the IPSS-voiding subscore, and the IPSS-storage subscore decreased and maximal uroflow increased significantly after 12 weeks of treatment. Whereas the baseline LF/HF ratio increased from 0.89±0.407 to 1.80±1.804 after treatment in group A, it decreased from 3.93±5.471 to 1.79±1.153 in group B. Conclusions: The efficacies of Xatral XL were clear in both groups. We found that the LF/HF ratio in the two groups merged to a value of approximately 1.79 after treatment. We suggest that this could be a clue to the importance of balance in autonomic nervous system activity in men with LUTS.https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-59-49.pdfAutonomic nervous systemProstateUrination
collection DOAJ
language English
format Article
sources DOAJ
author Kang Hee Shim
Tae Woo Kim
Byung Ha Chung
Sung Won Lee
Jong Kwan Park
Kwangsung Park
Jun Cheon
Kyung Seop Lee
Hyung-Jee Kim
Do-Hwan Seong
Seung-June Oh
Sae Woong Kim
Ji Youl Lee
Seol Ho Choo
Jong Bo Choi
spellingShingle Kang Hee Shim
Tae Woo Kim
Byung Ha Chung
Sung Won Lee
Jong Kwan Park
Kwangsung Park
Jun Cheon
Kyung Seop Lee
Hyung-Jee Kim
Do-Hwan Seong
Seung-June Oh
Sae Woong Kim
Ji Youl Lee
Seol Ho Choo
Jong Bo Choi
Changes in autonomic nervous system activity after treatment with alpha-blocker in men with lower urinary tract symptoms
Investigative and Clinical Urology
Autonomic nervous system
Prostate
Urination
author_facet Kang Hee Shim
Tae Woo Kim
Byung Ha Chung
Sung Won Lee
Jong Kwan Park
Kwangsung Park
Jun Cheon
Kyung Seop Lee
Hyung-Jee Kim
Do-Hwan Seong
Seung-June Oh
Sae Woong Kim
Ji Youl Lee
Seol Ho Choo
Jong Bo Choi
author_sort Kang Hee Shim
title Changes in autonomic nervous system activity after treatment with alpha-blocker in men with lower urinary tract symptoms
title_short Changes in autonomic nervous system activity after treatment with alpha-blocker in men with lower urinary tract symptoms
title_full Changes in autonomic nervous system activity after treatment with alpha-blocker in men with lower urinary tract symptoms
title_fullStr Changes in autonomic nervous system activity after treatment with alpha-blocker in men with lower urinary tract symptoms
title_full_unstemmed Changes in autonomic nervous system activity after treatment with alpha-blocker in men with lower urinary tract symptoms
title_sort changes in autonomic nervous system activity after treatment with alpha-blocker in men with lower urinary tract symptoms
publisher Korean Urological Association
series Investigative and Clinical Urology
issn 2466-0493
2466-054X
publishDate 2018-01-01
description Purpose: To determine changes in autonomic nervous system activity after treatment in men with lower urinary tract symptoms (LUTS), we evaluated changes in patients' symptoms, uroflowmetry, and heart rate variability (HRV) after treatment with alpha-blockers for 12 weeks. Materials and Methods: Ninety-five men who had LUTS (International Prostate Symptom Score [IPSS] ≥8) were included in this study. We divided them into two groups on the basis of a low frequency/high frequency (LF/HF) ratio of 1.6. After treatment with Xatral XL (Handok Inc., Korea) 10 mg for 3 months, we rechecked their IPSS, uroflowmetry, HRV and compared these with the baseline measurements. Results: Fifty-four men were assigned to the low LF/HF group (group A: LF/HF ≤1.6) and 41 men to the high LF/HF group (group B: LF/HF >1.6). At baseline and 12 weeks, none of the parameters differed significantly between the groups except for HF, which is one of the parameters of HRV. IPSS, the IPSS-voiding subscore, and the IPSS-storage subscore decreased and maximal uroflow increased significantly after 12 weeks of treatment. Whereas the baseline LF/HF ratio increased from 0.89±0.407 to 1.80±1.804 after treatment in group A, it decreased from 3.93±5.471 to 1.79±1.153 in group B. Conclusions: The efficacies of Xatral XL were clear in both groups. We found that the LF/HF ratio in the two groups merged to a value of approximately 1.79 after treatment. We suggest that this could be a clue to the importance of balance in autonomic nervous system activity in men with LUTS.
topic Autonomic nervous system
Prostate
Urination
url https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-59-49.pdf
work_keys_str_mv AT kangheeshim changesinautonomicnervoussystemactivityaftertreatmentwithalphablockerinmenwithlowerurinarytractsymptoms
AT taewookim changesinautonomicnervoussystemactivityaftertreatmentwithalphablockerinmenwithlowerurinarytractsymptoms
AT byunghachung changesinautonomicnervoussystemactivityaftertreatmentwithalphablockerinmenwithlowerurinarytractsymptoms
AT sungwonlee changesinautonomicnervoussystemactivityaftertreatmentwithalphablockerinmenwithlowerurinarytractsymptoms
AT jongkwanpark changesinautonomicnervoussystemactivityaftertreatmentwithalphablockerinmenwithlowerurinarytractsymptoms
AT kwangsungpark changesinautonomicnervoussystemactivityaftertreatmentwithalphablockerinmenwithlowerurinarytractsymptoms
AT juncheon changesinautonomicnervoussystemactivityaftertreatmentwithalphablockerinmenwithlowerurinarytractsymptoms
AT kyungseoplee changesinautonomicnervoussystemactivityaftertreatmentwithalphablockerinmenwithlowerurinarytractsymptoms
AT hyungjeekim changesinautonomicnervoussystemactivityaftertreatmentwithalphablockerinmenwithlowerurinarytractsymptoms
AT dohwanseong changesinautonomicnervoussystemactivityaftertreatmentwithalphablockerinmenwithlowerurinarytractsymptoms
AT seungjuneoh changesinautonomicnervoussystemactivityaftertreatmentwithalphablockerinmenwithlowerurinarytractsymptoms
AT saewoongkim changesinautonomicnervoussystemactivityaftertreatmentwithalphablockerinmenwithlowerurinarytractsymptoms
AT jiyoullee changesinautonomicnervoussystemactivityaftertreatmentwithalphablockerinmenwithlowerurinarytractsymptoms
AT seolhochoo changesinautonomicnervoussystemactivityaftertreatmentwithalphablockerinmenwithlowerurinarytractsymptoms
AT jongbochoi changesinautonomicnervoussystemactivityaftertreatmentwithalphablockerinmenwithlowerurinarytractsymptoms
_version_ 1725523752444231680